Somnomed Ltd
ASX:SOM
Somnomed Ltd
ASX:SOM
Price:
0.26 AUD
Market Closed
Updated:
May 28, 2024
Somnomed Ltd
Total Equity
|
Somnomed Ltd
Total Equity Peer Comparison
Comparables:
IPD
C
CYC
COH
OIL
EMV
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Somnomed Ltd
ASX:SOM
|
Total Equity
AU$29.9m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
|
ImpediMed Ltd
ASX:IPD
|
Total Equity
AU$51m
|
CAGR 3-Years
27%
|
CAGR 5-Years
14%
|
CAGR 10-Years
21%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Total Equity
AU$32.3m
|
CAGR 3-Years
24%
|
CAGR 5-Years
14%
|
CAGR 10-Years
24%
|
|
|
Cochlear Ltd
ASX:COH
|
Total Equity
AU$1.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
22%
|
CAGR 10-Years
19%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Total Equity
AU$16.4m
|
CAGR 3-Years
17%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Total Equity
AU$5.1m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
See Also
What is Somnomed Ltd's Total Equity?
Total Equity
29.9m
AUD
29.9m
AUD
Based on the financial report for Dec 31, 2023, Somnomed Ltd's Total Equity amounts to 29.9m AUD.
What is Somnomed Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
10%
10%
Over the last year, the Total Equity growth was 20%. The average annual Total Equity growth rates for Somnomed Ltd have been -4% over the past three years , 7% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet
